Publications

Miksad, RA, and Abernethy, AP. "Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality." Clinical Pharmacology and Therapeutics 103, no. 2 (February 1, 2018): 202-205.

Full Text

Liede, A, Wade, S, Lethen, J, Hernandez, RK, Warner, D, Abernethy, AP, and Finelli, A. "An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer." Clinical Therapeutics (February 2018).

Full Text

Tran, G, and Zafar, SY. "Price of Cancer Care and Its Tax on Quality of Life." Journal of oncology practice (January 30, 2018): JOP2017028498-.

PMID
29381412
Full Text

Koshkin, VS, Barata, PC, Zhang, T, George, DJ, Atkins, MB, Kelly, WJ, Vogelzang, NJ, Pal, SK, Hsu, J, Appleman, LJ, Ornstein, MC, Gilligan, T, Grivas, P, Garcia, JA, and Rini, BI. "Clinical activity of nivolumab in patients with non-clear cell renal cell carcinoma." Journal for immunotherapy of cancer 6, no. 1 (January 29, 2018): 9-.

PMID
29378660
Full Text

George, DJ, Martini, J-F, Staehler, M, Motzer, RJ, Magheli, A, Escudier, B, Gerletti, P, Li, S, Casy, M, Laguerre, B, Pandha, H, Pantuck, A, Patel, A, Lechuga, MJ, and Ravaud, A. "Immune biomarkers predictive for disease-free survival with adjuvant sunitinib in high-risk locoregional renal cell carcinoma: from randomized phase III S-TRAC study." Clinical cancer research : an official journal of the American Association for Cancer Research (January 26, 2018).

PMID
29374054
Full Text

Zhu, J, Armstrong, AJ, Friedlander, TW, Kim, W, Pal, SK, George, DJ, and Zhang, T. "Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond." Journal for immunotherapy of cancer 6, no. 1 (January 25, 2018): 4-. (Review)

PMID
29368638
Full Text

Brousell, SC, Fantony, JJ, Van Noord, MG, Harrison, MR, and Inman, BA. "Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract: an evidence-based review of safety, efficacy, and place in therapy." Core evidence 13 (January 24, 2018): 1-12. (Review)

PMID
29416444
Full Text

Garland Austin, R, Huang, TJ, Wu, M, Armstrong, AJ, and Zhang, T. "Clinical utility of non-EpCAM based circulating tumor cell assays." Advanced drug delivery reviews (January 20, 2018).

PMID
29366804
Full Text

Crosby, EJ, Wei, J, Yang, XY, Lei, G, Wang, T, Liu, CX, Agarwal, P, Korman, AJ, Morse, MA, Gouin, K, Knott, SRV, Lyerly, HK, and Hartman, ZC. "Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors (Accepted)." OncoImmunology (January 19, 2018).

Full Text

Dale, DC, Crawford, J, Klippel, Z, Reiner, M, Osslund, T, Fan, E, Morrow, PK, Allcott, K, and Lyman, GH. "A systematic literature review of the efficacy, effectiveness, and safety of filgrastim." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 26, no. 1 (January 2018): 7-20. (Review)

PMID
28939926
Full Text

Pages